India Chemical Stocks 2026: SRF, Pidilite, Deepak Nitrite, Navin Fluorine & Atul — ROCE, PE & Valuations

India's specialty chemicals sector endured a painful de-rating through FY24–25 as China flooded global markets with cheap intermediates, squeezed margins, and forced Indian producers to cut prices. By mid-2026, the sector is attempting a recovery — but stock-by-stock fundamentals vary sharply. Here is a ground-up look at five bellwether names using the latest audited data sourced from DocStoX data (NSE/BSE audited filings).

Sector Snapshot: Why Chemicals Matter in 2026

India's specialty chemicals industry supplies agrochemicals, fluorochemicals, adhesives, dyes, and pharma intermediates to global value chains. The "China+1" diversification thesis drove a massive re-rating from 2020–2022 before overcapacity in China caused a sharp reversal. In 2026, the question is which companies have the balance sheet strength and ROCE profile to survive margin pressure and emerge stronger.

Five Stocks, Side by Side

All figures are sourced live from DocStoX data (NSE audited filings, prices as of 9 July 2026).

Pidilite Industries — Premium Franchise, Premium Price

Pidilite (₹1,61,823 Cr market cap) is the undisputed quality leader in this cohort. Its ROCE of 31% — the highest in the group — reflects the near-monopoly pricing power of the Fevicol brand in adhesives and construction chemicals. Revenue stands at ₹14,601 Cr and the balance sheet is essentially debt-free (D/E of just 0.04).

The flip side: a PE of 66x leaves little room for earnings misses. The stock trades near its 52-week low of ₹1,259, having fallen sharply from a high of ₹3,150. Investors must decide whether the premium quality justifies paying up, or whether mean reversion on the multiple still has further to run.

SRF Ltd — Diversified but Cyclical

SRF's ₹15,787 Cr revenue is the largest in this peer group, reflecting its diversified business: fluorochemicals, specialty chemicals, technical textiles, and packaging films. However, this breadth comes with cyclicality. ROCE at 15% is moderate, and the debt-to-equity of 0.36 reflects capex investments in the chemicals vertical. PE of 44.5x is high given the current earnings cycle. The 52-week range of ₹2,355–₹3,325 shows the stock remains well off peak, offering a more reasonable entry than at 2022 highs.

Navin Fluorine — High-ROCE Fluorochemicals Play

Navin Fluorine is the pure-play fluorochemicals name in the group. With ROCE of 21% and ROE of 20.3%, it ranks second only to Pidilite on capital efficiency. Revenue at ₹3,314 Cr is the smallest here, but the business commands high margins given the complexity of CRAMS (Contract Research and Manufacturing Services) fluorochemical synthesis. At ₹7,689 and a PE of 59.4x, the market is pricing in strong execution on its long-term CRAMS pipeline. The stock sits just below its 52-week high of ₹7,810, suggesting momentum is returning.

Deepak Nitrite — Recovery Story at a Reasonable PE

Deepak Nitrite has had the most difficult two years in this peer set. ROCE of 11% and ROE of just under 10% reflect the cyclical downturn in nitro-aromatics and phenol intermediates. Revenue of ₹7,887 Cr gives it decent scale, and the balance sheet is manageable (D/E 0.28). The redeeming factor is valuation: at PE 40.2x — the second-lowest here — it prices in a meaningful portion of the cycle. If phenol spreads recover through FY27, earnings could re-rate significantly.

Atul Ltd — Cheapest Multiple, Debt-Free Balance Sheet

Atul Ltd's PE of 26.9x is the lowest in this group — notable given its completely debt-free balance sheet (D/E of 0.03). Revenue stands at ₹6,274 Cr, spanning performance chemicals and life-science chemicals. ROCE of 15% is reasonable. The book value of ₹2,113 per share against a market price of ₹6,183 implies a price-to-book of roughly 2.9x — modest for a specialty chemicals company of this quality. For value-oriented investors, Atul often gets overlooked behind the more prominent names, which is partly why the multiple stays compressed.

Key Takeaways

• ROCE leader: Pidilite (31%) — but priced at 66x PE.
• Best capital efficiency + growth optionality: Navin Fluorine (ROCE 21%, near 52-week highs).
• Cheapest on PE: Atul (26.9x) with zero meaningful debt.
• Recovery bet: Deepak Nitrite (ROCE 11% — cyclically depressed, 40x PE).
• Scale play: SRF (largest revenue ₹15,787 Cr, moderate ROCE 15%).

Risks to Watch

The biggest systemic risk for the entire sector remains Chinese overcapacity in basic chemical intermediates. Even specialty players source some raw materials from China, making margin profiles sensitive to currency and trade policy. Domestically, raw material inflation — particularly crude-linked feedstocks — can compress EBITDA margins quickly. Investors should track quarterly EBITDA margin trends alongside volume growth to distinguish structural recovery from cyclical noise.

This is for informational purposes only and not investment advice. Please consult a SEBI-registered advisor before investing.